Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Mc3T3-El¼¼Æ÷ÀÇ ALP activity¿¡ ´ëÇÑ IGF-IÀÇ ¿µÇâ

The Effect of IGF-1 on ALP Activity of MC3T3-E1 Cell

´ëÇÑÄ¡ÁÖ°úÇÐȸÁö 1997³â 27±Ç 4È£ p.669 ~ 684
ÃÖ¿¬Èñ, ¹è°Ç¼º, ÀÌÁø¼ö, ÀÌ¿µÀº, ¼Û±Ù¹è,
¼Ò¼Ó »ó¼¼Á¤º¸
ÃÖ¿¬Èñ (  ) - °æºÏ´ëÇб³ Ä¡°ú´ëÇÐ Ä¡ÁÖ°úÇб³½Ç
¹è°Ç¼º (  ) - °æºÏ´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­»ýÈ­Çб³½Ç
ÀÌÁø¼ö (  ) - °æºÏ´ëÇб³ Ä¡°ú´ëÇÐ Ä¡°ú¾à¸®Çб³½Ç
ÀÌ¿µÀº (  ) - °æºÏ´ëÇб³ Ä¡°ú´ëÇÐ Ä¡ÁÖ°úÇб³½Ç
¼Û±Ù¹è (  ) - °æºÏ´ëÇб³ Ä¡°ú´ëÇÐ Ä¡ÁÖ°úÇб³½Ç

Abstract


Polypeptide growth factors belong to a class of potent biologic mediators which regulate cell differentiation, proliferation, migration and metabolism. IGF-I is polypeptides secreted by skeletal cells and is considered as regulators of bone formation. The purpose of this study is to evaluate the effects of IGF-I on bone nodule formation and alkaline phosphatase activity of MC3T3-El cells.
MC3T3-El cells were seeded at 1 x 104 cells/well, 1 x 105 cells/well in alpha-modified Eagle medium containing 10% fetal bovine serum, 10 mM fl-glycerophosphate and 50ug/ml of ascorbic acid. Before 48 hours of indicated time, medium were changed with serum free medium. After 24 hours, 0.1, 1, 10 ng/ml IGF-I were added to the cells and cultured for 3, 7, 14, 21, 28 clays. And histochemical analysis was done and ALP activity was measured and was expressed as nmol/min/mg of protein.
The bone nodule formation in MC3T3-E1 cells of IGF-I was seen at 21, 28 days, but there were no difference between control group and experimental groups.
The ALP activity decreased when it is compare to control 2 group except for 1 ng/ml, 10 ng/ml IGF-I of 21-day-groups and 1 ng/ml IGF-I of 28-day-groups.
Dose response effects of IGF-I of ALP activity in MC3T3-E1 cells were seen the highest ALP activity at lng/ml until 2ldays and the highest ALP activity at 10 ng/ml of 28 daygroups.
The peak times were seen at 7-day group, 14-day group on control group and experimental group respectively, and 1 ng/ml group was the highest ALP activity.
From the above results, IGF-I was not seen notable effect on bone nodule formation and decreased ALP activity of MC3T3-E1 cells but the use of IGF-I to mediate biological stimulation of MC3T3-E1 cells shows promise for future therapeutic application.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI